GlassScriptPhysician profile
Steven M Burtner
NPI 1801205588
$4,189.96
in general payments reported to CMS, 2019-2025
32 companies · $818 in 2025
The $818 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $676 · 2022: $934 · 2023: $1,221 · 2024: $541 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,495 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,495.07 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,029.27 | 2021-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $774.72 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Abiomed | $441.84 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $318.06 | 2021-2025 | Ofev, Stiolto Respimat, Jascayd |
| Merck Sharp & Dohme LLC | $192.05 | 2021-2025 | Zerbaxa, Recarbrio, Dificid |
| Takeda Pharmaceuticals U.S.A., INC. | $189.68 | 2022-2025 | Glassia, Cuvitru |
| Actelion Pharmaceuticals US, INC. | $187.50 | 2022-2024 | Uptravi, Opsumit |
| United Therapeutics Corporation | $99.67 | 2023-2024 | Tyvaso |
| Novartis Pharmaceuticals Corporation | $83.91 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $79.03 | 2022-2023 | Dupixent |
| Inogen, INC. | $65.36 | 2023-2024 | Inogen |
| Axsome Therapeutics, INC. | $64.66 | 2022-2024 | Sunosi |
| Insmed, INC. | $59.39 | 2021-2023 | Arikayce |
| Abbvie INC. | $57.57 | 2024-2025 | |
| Viatris Specialty LLC | $52.94 | 2025 | Yupelri |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $51.04 | 2022-2024 | |
| Amgen INC. | $48.15 | 2022-2024 | Tezspire |
| Mallinckrodt Hospital Products INC. | $47.31 | 2022-2023 | Acthar |
| Lilly USA, LLC | $40.92 | 2025 | Zepbound |
| Grifols USA, LLC | $39.38 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $34.25 | 2022-2023 | Quviviq |
| Ani Pharmaceuticals, INC. | $34.03 | 2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $29.71 | 2025 | Xolair |
| Paratek Pharmaceuticals, INC. | $27.62 | 2022 | |
| Edwards Lifesciences Corporation | $27.39 | 2023 | Hemosphere |
| Bayer Healthcare Pharmaceuticals INC. | $22.63 | 2022 | |
| Jazz Pharmaceuticals INC. | $20.09 | 2023 | |
| Pfizer INC. | $15.37 | 2022 | |
| Baxter Healthcare | $14.56 | 2023 | Hillrom - Life 2000 Ventilation System |
| Csl Behring | $14.54 | 2025 | Kcentra |
| Shionogi INC | $13.85 | 2021 | |
| Alexion Pharmaceuticals, INC. | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Burtner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.